trending Market Intelligence /marketintelligence/en/news-insights/trending/nupGvAKVQubthbsLy8fCgA2 content esgSubNav
In This List

Actinium Pharmaceuticals appoints CEO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Actinium Pharmaceuticals appoints CEO

Actinium Pharmaceuticals Inc. appointed Sandesh Seth as its CEO.

Seth, who is also the company's chairman, will replace Kaushik Dave, who resigned May 12.

Seth is joined by Steve O'Loughlin, who was promoted to the position of principal financial and accounting officer from vice president of corporate finance and development.

Sergio Traversa resigned from the company's board.